Imaging Endpoints Was Founded to Connect Imaging to the Cure™

March 3, 2022 – Imaging Endpoints was founded to connect Imaging to the Cure™ and is making its vision a reality by being at the forefront of clinical trial research with ongoing clinical trials on cancer in all its forms. Our advanced imaging technologies assist clients in uncovering diverse biologic associations using non-invasive imaging modalities such as CT, MRI and PET. Targeted therapies can be tracked and monitored on a molecular level, leading to a deeper, richer evaluation, and ultimately a more effective trial design. Our services and technologies allow us to provide clinical trials with more sophisticated information without affecting data capture workflow. The fusion of new therapeutics, imaging, and biomarker development is directing us into an advanced realm of healthcare delivery. Learn more about our deep imaging services at https://imagingendpoints.com/research-services/.